|
|
Volumn 41, Issue 7, 2002, Pages 441-443
|
|
Treatment of cutaneous leishmaniasis with a combination of allopurinol and low-dose meglumine antimoniate
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALLOPURINOL;
MEGLUMINE ANTIMONATE;
ABDOMINAL PAIN;
ADULT;
ANTIPROTOZOAL ACTIVITY;
CHILD;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE DURATION;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG ERUPTION;
DRUG TOLERABILITY;
FEMALE;
HEALING;
HUMAN;
LEISHMANIA MAJOR;
MAJOR CLINICAL STUDY;
MALE;
MUSCLE WEAKNESS;
MYALGIA;
NAUSEA;
RANDOMIZATION;
RANDOMIZED CONTROLLED TRIAL;
SKIN LEISHMANIASIS;
TREATMENT FAILURE;
TREATMENT PLANNING;
VOLUNTEER;
ADOLESCENT;
ADULT;
ALLOPURINOL;
ANTIMETABOLITES;
ANTIPROTOZOAL AGENTS;
CHILD;
CHILD, PRESCHOOL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
LEISHMANIASIS, CUTANEOUS;
MALE;
MEGLUMINE;
MIDDLE AGED;
ORGANOMETALLIC COMPOUNDS;
TREATMENT OUTCOME;
|
|
EID: 0036057204
PISSN: 00119059
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-4362.2002.01527.x Document Type: Conference Paper |
|
Times cited : (69)
|
|
References (14)
|
